GlassScriptPhysician profile
Macey K Gettinger
NPI 1912528126
$2,179.52
in general payments reported to CMS, 2019-2025
18 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $829 · 2022: $631 · 2023: $343 · 2024: $210 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $657.13 | 2021-2025 | |
| Novo Nordisk INC | $425.16 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $224.20 | 2021-2022 | |
| Amgen INC. | $164.49 | 2021-2024 | Repatha |
| Lilly USA, LLC | $122.96 | 2021-2025 | Zepbound, Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $121.16 | 2024-2025 | Caplyta |
| Glaxosmithkline, LLC. | $95.96 | 2021-2022 | |
| Boston Scientific Corporation | $88.74 | 2021 | |
| Daiichi Sankyo INC. | $68.22 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $46.06 | 2021-2022 | |
| Mylan Specialty L.P. | $39.93 | 2021 | |
| Allergan, INC. | $30.91 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $18.74 | 2021 | |
| Exact Sciences Corporation | $17.50 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.17 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.70 | 2022 | |
| Dexcom, INC. | $13.88 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macey Gettinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.